Skip to main content
Top
Published in: Abdominal Radiology 5/2019

01-05-2019 | Computed Tomography | Hollow Organ GI

Analyzing the post-contrast attenuation of the esophageal wall on routine contrast-enhanced MDCT examination can improve the diagnostic accuracy in response evaluation of the squamous cell esophageal carcinoma to neoadjuvant chemoradiotherapy in comparison with the esophageal wall thickness

Authors: Aleksandra Djuric-Stefanovic, Aleksandra Jankovic, Dusan Saponjski, Marjan Micev, Suzana Stojanovic-Rundic, Milena Cosic-Micev, Predrag Pesko

Published in: Abdominal Radiology | Issue 5/2019

Login to get access

Abstract

Purpose

To evaluate the accuracy of the multidetector computed tomography (MDCT) in the response evaluation of the esophageal squamous cell carcinoma (ESCC) to neoadjuvant chemoradiotherapy (nCRT) by analyzing the thickness and post-contrast attenuation of the esophageal wall after the nCRT.

Methods

Contrast-enhanced (CE)-MDCT examinations in portal venous phase of one hundred patients with locally advanced ESCC who received nCRT and underwent esophageal resection and histopathology assessment of tumor regression grade (TRG) were retrospectively analyzed by measuring the maximal thickness and mean density of the esophageal wall in the segment involved by tumor and visually searching for hyperdense foci within it. Diagnostic performance was evaluated using the ROC analysis.

Results

Average attenuation of the esophageal wall had stronger diagnostic performance for predicting pathologic complete regression (pCR) (AUC = 0.994; p < 0.001) in relation to maximal esophageal wall thickness (AUC = 0.731; p < 0.001). Maximal esophageal wall thickness ≤ 9 mm and average attenuation of the esophageal wall ≤ 64 HU predicted pCR with the sensitivity, specificity, and overall accuracy of 62.5%, 77.9%, and 73%, and 96.9%, 98.5%, and 98%, respectively. Combination of both cutoff values enabled correct assessment of pCR with the 100% accuracy. Visual detection of the hyperdense focus within the esophageal wall predicted pCR with the sensitivity, specificity, and overall accuracy values of 100%, 94.1%, and 96%, respectively.

Conclusion

Visual analysis and measurement of post-contrast attenuation of the esophageal wall after the nCRT can improve diagnostic accuracy of MDCT in the response evaluation of the ESCC to nCRT in comparison with measuring the esophageal wall thickness.
Literature
1.
go back to reference Worni M, Casteleberry AW, Gloor B et al. (2014) Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008. Dis Esophagus 27:662-669CrossRefPubMed Worni M, Casteleberry AW, Gloor B et al. (2014) Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008. Dis Esophagus 27:662-669CrossRefPubMed
3.
go back to reference van Hagen P, Hulshof MC, van Lanschot JJ et al. (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074-2084CrossRefPubMed van Hagen P, Hulshof MC, van Lanschot JJ et al. (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074-2084CrossRefPubMed
4.
go back to reference Stahl M, Stuschke M, Lehmann N et al. (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310-2317CrossRefPubMed Stahl M, Stuschke M, Lehmann N et al. (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310-2317CrossRefPubMed
5.
go back to reference Mandard AM, Dalibard F, Mandard JC et al. (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 73: 2680-2686CrossRefPubMed Mandard AM, Dalibard F, Mandard JC et al. (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 73: 2680-2686CrossRefPubMed
6.
go back to reference Rankin SC (2007) Oesophageal cancer: assessment of response and follow up. Cancer Imaging 7:67-69CrossRef Rankin SC (2007) Oesophageal cancer: assessment of response and follow up. Cancer Imaging 7:67-69CrossRef
7.
go back to reference Swisher SG, Maish M, Erasmus JJ et al. (2004) Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78:1152-1160CrossRefPubMed Swisher SG, Maish M, Erasmus JJ et al. (2004) Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78:1152-1160CrossRefPubMed
8.
go back to reference Schieman C, Wigle DA, Deschamps C et al. (2012) Patterns of operative mortality following esophagectomy. Dis Esophagus 25:645-651CrossRefPubMed Schieman C, Wigle DA, Deschamps C et al. (2012) Patterns of operative mortality following esophagectomy. Dis Esophagus 25:645-651CrossRefPubMed
9.
go back to reference Taketa T, Correa AM, Suzuki A et al. (2012) Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology 83:300-304CrossRefPubMed Taketa T, Correa AM, Suzuki A et al. (2012) Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology 83:300-304CrossRefPubMed
10.
go back to reference Cooper SL, Russo JK, Chin S (2012) Definitive chemoradiotherapy for esophageal carcinoma. Surg Clin North Am 92:1213-1248CrossRefPubMed Cooper SL, Russo JK, Chin S (2012) Definitive chemoradiotherapy for esophageal carcinoma. Surg Clin North Am 92:1213-1248CrossRefPubMed
11.
go back to reference Noordman BJ, Spaander MC, Valkema R et al. (2018) Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study. Lancet Oncology 19:965-974CrossRefPubMed Noordman BJ, Spaander MC, Valkema R et al. (2018) Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study. Lancet Oncology 19:965-974CrossRefPubMed
12.
go back to reference Boone J, Livestro DP, Elias G, Borel Rinkes HM, van Hillegersberg R (2009) International survey on esophageal cancer: part II staging and neoadjuvant therapy. Dis Esophagus 22:203–210CrossRefPubMed Boone J, Livestro DP, Elias G, Borel Rinkes HM, van Hillegersberg R (2009) International survey on esophageal cancer: part II staging and neoadjuvant therapy. Dis Esophagus 22:203–210CrossRefPubMed
13.
go back to reference Westerterp M, van Westreenen HL, Reitsma JB et al. (2005) Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy—systematic review. Radiology 236:841–851CrossRefPubMed Westerterp M, van Westreenen HL, Reitsma JB et al. (2005) Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy—systematic review. Radiology 236:841–851CrossRefPubMed
14.
go back to reference Cerfolio RJ, Bryant AS, Ohja B, et al. (2005) The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 129:1232-1241CrossRefPubMed Cerfolio RJ, Bryant AS, Ohja B, et al. (2005) The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 129:1232-1241CrossRefPubMed
15.
go back to reference Griffith JF, Chan AC, Chow LT, et al. (1999) Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT. Br J Radiol 72:678-684CrossRefPubMed Griffith JF, Chan AC, Chow LT, et al. (1999) Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT. Br J Radiol 72:678-684CrossRefPubMed
16.
go back to reference Jones D, Parker L, Detterbeck F, Egan T (1999) Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. Cancer 85:1026-1032CrossRefPubMed Jones D, Parker L, Detterbeck F, Egan T (1999) Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. Cancer 85:1026-1032CrossRefPubMed
17.
go back to reference Konieczny А, Meyer P, Schnider A, et al. (2013) Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer. Eur Radiol 23:2492–2502CrossRefPubMed Konieczny А, Meyer P, Schnider A, et al. (2013) Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer. Eur Radiol 23:2492–2502CrossRefPubMed
18.
go back to reference Ulla M, Gentile EM, Yeyati EL et al. (2013) Pneumo-CT assessing response to neoadjuvant therapy in esophageal cancer: Imaging-pathological correlation. World J Gastrointest Oncol 5:222-229CrossRefPubMedPubMedCentral Ulla M, Gentile EM, Yeyati EL et al. (2013) Pneumo-CT assessing response to neoadjuvant therapy in esophageal cancer: Imaging-pathological correlation. World J Gastrointest Oncol 5:222-229CrossRefPubMedPubMedCentral
19.
go back to reference Sobin LH, Gospodarowicz MK, Wittekind Ch (2009) UICC International Union Against Cancer TNM classification of malignant tumors, 7th edition. Wiley-Blackwell, Chichester Sobin LH, Gospodarowicz MK, Wittekind Ch (2009) UICC International Union Against Cancer TNM classification of malignant tumors, 7th edition. Wiley-Blackwell, Chichester
20.
go back to reference Li SH, Rau KM, Lu HI et al. (2012) Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3–4 oesophageal squamous cell carcinoma. Eur J of Cardiothorac Surg 42:958–964CrossRef Li SH, Rau KM, Lu HI et al. (2012) Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3–4 oesophageal squamous cell carcinoma. Eur J of Cardiothorac Surg 42:958–964CrossRef
21.
go back to reference Li R, Chen TW, Wang LY et al. (2012) Quantitative measurement of contrast enhancement of esophageal squamous cell carcinoma on clinical MDCT. World J Radiol 4:179-185CrossRefPubMedPubMedCentral Li R, Chen TW, Wang LY et al. (2012) Quantitative measurement of contrast enhancement of esophageal squamous cell carcinoma on clinical MDCT. World J Radiol 4:179-185CrossRefPubMedPubMedCentral
22.
go back to reference Chen YM, Pan XF, Tong LJ, Shi YP, Chen T (2011) Can 18F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis. Nucl Med Commun 32:1005-1010CrossRefPubMed Chen YM, Pan XF, Tong LJ, Shi YP, Chen T (2011) Can 18F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis. Nucl Med Commun 32:1005-1010CrossRefPubMed
23.
go back to reference Cong L, Wang S, Gao T, Hu L (2016) The predictive value of 18F-FDG PET for pathological response of primary tumor in patients with esophageal cancer during or after the neoadjuvant chemoradiotherapy: a meta-analysis. Jpn J Clin Oncol 46:1118-1126PubMed Cong L, Wang S, Gao T, Hu L (2016) The predictive value of 18F-FDG PET for pathological response of primary tumor in patients with esophageal cancer during or after the neoadjuvant chemoradiotherapy: a meta-analysis. Jpn J Clin Oncol 46:1118-1126PubMed
24.
go back to reference Qiu B, Wang D, Yang H et al. (2016) Combined modalities of magnetic resonance imaging, endoscopy and computed tomography in the evaluation of tumor responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma. Radiotherapy and Oncology 121:239-245CrossRefPubMed Qiu B, Wang D, Yang H et al. (2016) Combined modalities of magnetic resonance imaging, endoscopy and computed tomography in the evaluation of tumor responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma. Radiotherapy and Oncology 121:239-245CrossRefPubMed
26.
go back to reference Karmazanovsky G, Buryakina S, Kondratiev V, Yang Q, Ruchkin D, Kalinin D (2015) Value of two-phase dynamic multidetector computed tomography in differential diagnosis of post-inflammatory strictures from esophageal cancer. World J Gastroenterol 21:8878-8887CrossRefPubMedPubMedCentral Karmazanovsky G, Buryakina S, Kondratiev V, Yang Q, Ruchkin D, Kalinin D (2015) Value of two-phase dynamic multidetector computed tomography in differential diagnosis of post-inflammatory strictures from esophageal cancer. World J Gastroenterol 21:8878-8887CrossRefPubMedPubMedCentral
27.
go back to reference Koukourakis M, Fountzilas G, Sivridis E, Gatter C, Harris A (2000) Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy. Clin Cancer Res 6:381-389PubMed Koukourakis M, Fountzilas G, Sivridis E, Gatter C, Harris A (2000) Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy. Clin Cancer Res 6:381-389PubMed
28.
go back to reference Choi H (2008) Response Evaluation of Gastrointestinal Stromal Tumors. The Oncologist 13(suppl 2):4-7CrossRefPubMed Choi H (2008) Response Evaluation of Gastrointestinal Stromal Tumors. The Oncologist 13(suppl 2):4-7CrossRefPubMed
29.
go back to reference Schmidt N, Hess V, Zumbrunn T, Rothermundt C, Bongartz G, Potthast S (2013) Choi response criteria for prediction of survival in patients with metastatic renal cell carcinoma treated with anti-angiogenic therapies. Eur Radiol 23:632–639PubMed Schmidt N, Hess V, Zumbrunn T, Rothermundt C, Bongartz G, Potthast S (2013) Choi response criteria for prediction of survival in patients with metastatic renal cell carcinoma treated with anti-angiogenic therapies. Eur Radiol 23:632–639PubMed
30.
go back to reference Gavanier M, Ayav A, Sellal C, et al. (2016) CT imaging findings in patients with advanced hepatocellular carcinoma treated with sorafenib: Alternative response criteria (Choi, European Association for the Study of the Liver, and modified Response Evaluation Criteria in Solid Tumor (mRECIST) versus RECIST 1.1. Eur J Radiol 85:103–112CrossRefPubMed Gavanier M, Ayav A, Sellal C, et al. (2016) CT imaging findings in patients with advanced hepatocellular carcinoma treated with sorafenib: Alternative response criteria (Choi, European Association for the Study of the Liver, and modified Response Evaluation Criteria in Solid Tumor (mRECIST) versus RECIST 1.1. Eur J Radiol 85:103–112CrossRefPubMed
31.
go back to reference Hwang SH, Yoo MR, Park CH, et al (2013) Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy. Eur Radiol 23:1573-1581CrossRefPubMed Hwang SH, Yoo MR, Park CH, et al (2013) Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy. Eur Radiol 23:1573-1581CrossRefPubMed
33.
go back to reference Chung WS, Park MS, Shin SJ et al. (2012) Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria. Am J Roentgenol 199:809-815CrossRef Chung WS, Park MS, Shin SJ et al. (2012) Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria. Am J Roentgenol 199:809-815CrossRef
34.
go back to reference Tian F, Hayano K, Kambadakone AR, Sahani DV (2015) Response assessment to neoadjuvant therapy in soft tissue sarcomas: using CT texture analysis in comparison to tumor size, density, and perfusion. Abdom Imaging 40:1705-1712CrossRefPubMed Tian F, Hayano K, Kambadakone AR, Sahani DV (2015) Response assessment to neoadjuvant therapy in soft tissue sarcomas: using CT texture analysis in comparison to tumor size, density, and perfusion. Abdom Imaging 40:1705-1712CrossRefPubMed
35.
go back to reference Baliyan V, Kordbacheh H, Parakh A, Kambadakone A (2018) Response assessment in pancreatic ductal adenocarcinoma: role of imaging. Abdom Imaging 43:435-444CrossRef Baliyan V, Kordbacheh H, Parakh A, Kambadakone A (2018) Response assessment in pancreatic ductal adenocarcinoma: role of imaging. Abdom Imaging 43:435-444CrossRef
36.
go back to reference Marchegiani G, Todaro V, Boninsegna E, et al. (2018) Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumor attenuation on CT correlates with R0 resection. Eur Radiol 28:4265–4273CrossRefPubMed Marchegiani G, Todaro V, Boninsegna E, et al. (2018) Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumor attenuation on CT correlates with R0 resection. Eur Radiol 28:4265–4273CrossRefPubMed
37.
go back to reference Umeoka S, Koyama T, Togashi K, et al. (2006) Esophageal cancer: evaluation with triple-phase dynamic CT-initial experience. Radiology 239:777-783CrossRefPubMed Umeoka S, Koyama T, Togashi K, et al. (2006) Esophageal cancer: evaluation with triple-phase dynamic CT-initial experience. Radiology 239:777-783CrossRefPubMed
Metadata
Title
Analyzing the post-contrast attenuation of the esophageal wall on routine contrast-enhanced MDCT examination can improve the diagnostic accuracy in response evaluation of the squamous cell esophageal carcinoma to neoadjuvant chemoradiotherapy in comparison with the esophageal wall thickness
Authors
Aleksandra Djuric-Stefanovic
Aleksandra Jankovic
Dusan Saponjski
Marjan Micev
Suzana Stojanovic-Rundic
Milena Cosic-Micev
Predrag Pesko
Publication date
01-05-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 5/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-01911-w

Other articles of this Issue 5/2019

Abdominal Radiology 5/2019 Go to the issue

Classics in Abdominal Radiology

Sentinel clot sign in hemoperitoneum

Classics in Abdominal Radiology

The “maiden waist” sign of the ureters

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.